drug combinations

Terminated contract
Biotech

Boundless scraps combo treatment of 2 unimpressive cancer drugs

Boundless Bio has finally given up on hopes of finding redemption for two solid tumor drugs that had come up short in the clinic.
James Waldron Jan 20, 2026 9:00am
Cartoon of businessmen standing around a broken target

Arcus halts Gilead-partnered TIGIT trials as it reworks R&D

Dec 12, 2025 10:00am
graphic image of different colored hands shaking

Crescent inks $80M Kelun deal, adding ADC to mix with bispecific

Dec 4, 2025 9:50am
Graphic image of an arrow nailing the bullseye of a target

Exelixis beats Bayer drug in cancer trial, sending stock higher

Jun 23, 2025 7:30am
Large layoffs of employees Wooden figures of people going to the exit

Boundless Bio lays off 33% of staff as lead program stumbles

May 27, 2025 8:40am
Step closer race run

Immutep's LAG-3 agent posts 'impressive' survival data

May 5, 2025 10:37am